US 11629145
SHP2 phosphatase inhibitors and methods of use thereof
granted A61PA61P3/00A61P35/00
Quick answer
US patent 11629145 (SHP2 phosphatase inhibitors and methods of use thereof) held by Relay Therapeutics, Inc. expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relay Therapeutics, Inc.
- Grant date
- Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P3/00, A61P35/00, A61P7/00